.png)
Where We Work?
Our reach is global, but our knowledge is local. We support pharmaceutical companies across:Region
Our Focus French West Africa Local compliance, distribution, tenders
West & Central Africa, Government and private sector partnerships, India Export readiness and global dossier compliance.
LATAM Distributor matching and market launch.
GCC Product positioning and regulatory pathways
SEA Country-specific strategies and risk managementRussia & CISRegulatory localization and documentationWe specialize in helping pharma businesses scale in both regulated and semi-regulated markets.
Pharma Business Consultancy for Global Manufacturers
Entering Africa and Beyond...
Opening Doors to New Pharma Markets
Welcome to AUM CONSULTANCY BJ,
your trusted partner in global pharma expansion.
We help pharmaceutical manufacturers like you succeed in high-growth, complex markets—whether it’s French West Africa, Africa, LATAM, the GCC, Southeast Asia, Russia, the CIS, or India.
As experts in pharma business consultancy, our goal is simple: make your market entry and growth as seamless, compliant, and profitable as possible.
What We Do ?
Expanding into new territories is full of opportunity—but also full of regulatory, cultural, and operational challenges. That’s where we come in.
We offer strategic, on-the-ground support for:
-
Pharmaceutical market access in Africa
-
Regulatory support for pharma manufacturers
-
Third-party manufacturing support
-
Pharma export consultancy for LATAM, GCC, and SEA
-
End-to-end pharma solutions for sustainable growth
Whether you need help registering your products, finding the right manufacturing partner, or building a distribution network, we’re here to help you move with clarity and confidence.
Why Choose AUM CONSULTANCY BJ?
Who We Work With?
We partner with:
-
Brand & Generic drug manufacturers looking to enter Africa.
-
API exporters needing regulatory alignment.
-
Nutraceutical and supplement companies seeking global distribution.
-
Biotech firms looking for local partners.
-
OTC brands expanding into multilingual regions.
-
Healthcare distributors needing registration and compliance support.
No matter your product or scale, our pharma business consultancy services are designed to meet your needs.
-
We’re not just consultants—we’re doers.
-
Here’s why pharma manufacturers around the world work with us:
-
12+ years of experience in French-speaking Africa Licensed importer in Benin with access to private and public tenders.
-
Multilingual team fluent in English, French, and local languages.
-
Trusted network of regulators, distributors, and CMOs
-
Tailored approach for generics, biosimilars, APIs, nutraceuticals, and more.
-
We provide actionable strategies, local execution, and measurable results.
How We Help?
-
We tailor our services to support your full business lifecycle:
-
Regulatory Support for Pharma Manufacturers.
-
We help prepare and submit dossiers, respond to local authority queries, and fast-track approvals.
-
Pharma Export Consultancy for LATAM, GCC, SEA.
-
From documentation to distributor due diligence—we simplify cross-border pharma trade.
-
Pharmaceutical Market Access in Africa.
-
We open doors to hospitals, pharmacies, and government procurement systems.
-
Third-Party Manufacturing Support.
-
We connect you with audited GMP-certified manufacturers that match your quality and capacity needs.
-
End-to-End Pharma Solutions.
-
From market strategy to daily operations—we cover it all, so you can focus on growth.
Let’s Grow Together.......
-
If you’re ready to grow your pharmaceutical business into new markets, we’re ready to guide the way.
-
AUM CONSULTANCY BJ brings together deep industry experience, trusted relationships, and market know-how to make your global expansion successful.
-
🌐 Visit: www.aumconsultancybj.com
-
Email us at: support@aumconsultancybj.com
Your Trusted Partner for Pharma Sales & Marketing in Africa
Africa is one of the most diverse and promising regions for pharmaceutical growth — but it’s also incredibly nuanced. Each country, each zone, comes with its own rules, languages, business cultures, and customer needs. That’s where we come in.
At AUM Consultancy, we specialize in helping pharma manufacturers, global investors, NGOs, and procurement teams confidently step into African markets. We don’t just offer advice — we design practical sales and marketing strategies, connect you with trusted local partners, and guide you through the entire journey from regulatory clearance to product promotion.
Here’s how we break Africa into five key zones, and how our team tailors your strategy for each one.
Sales & Marketing Strategy Across Africa’s Key Regions
1. North Africa
Countries: Algeria, Egypt, Morocco, Tunisia, Libya, Sudan
North Africa offers a relatively well-regulated and competitive landscape. Here, success is built on deep local relationships and clear alignment with government tenders and hospital systems.
What Works:
-
Marketing materials in Arabic and French
-
Collaboration with local distributors and medical reps
-
Therapeutic focus on chronic diseases like diabetes, hypertension, and oncology
What We Do:
We help you set up the right partnerships, manage your registration with local regulators like EDA (Egypt) and DPM (Morocco), and ensure your message resonates with both public and private stakeholders.
2. West Africa
Countries: Nigeria, Ghana, Senegal, Côte d’Ivoire, Togo, Benin, Mali, Guinea, Niger, Liberia, Sierra Leone, Gambia
West Africa is vibrant, fast-moving, and full of opportunity — especially in Nigeria, the continent’s most populous nation. But price sensitivity and regulatory hurdles make it essential to have a strong local game plan.
Smart Strategies:
-
Leverage government and NGO tenders
-
Engage trusted local distributors
-
Use health awareness campaigns for market education
How We Help:
We support everything from NAFDAC approvals to distributor sourcing, pricing strategy, and rep training — so your product gets into the right hands, the right way.
3. East Africa
Countries: Kenya, Ethiopia, Uganda, Tanzania, Rwanda, Burundi, Somalia, South Sudan, Djibouti, Eritrea
East Africa is moving forward fast, especially with the EAC (East African Community) helping harmonize regulations. Kenya and Ethiopia are the big players here — both are excellent starting points for regional expansion.
Sales Drivers:
-
Thought-leadership via medical conferences and CME programs
-
Distribution into both public procurement and private clinics
-
Strong presence in high-impact therapeutic areas like infectious diseases
Our Role:
We guide you through regional registrations, help you connect with influential healthcare professionals, and even localize your marketing to ensure your message is clear, culturally relevant, and compliant.
4. Central Africa
Countries: Cameroon, DR Congo, Republic of Congo, Chad, CAR, Gabon, Equatorial Guinea
This region is under-served, yet full of potential. Infrastructure and regulatory consistency are still developing — but that’s what creates a first-mover advantage for companies ready to invest smartly.
Your Edge:
-
Opportunity to lead in lesser-known therapeutic categories
-
Potential for brand-building in unbranded or generic-dominated markets
-
Benefit from strong on-the-ground partnerships
Where We Step In:
We conduct local feasibility studies, identify trustworthy distribution partners, and help you build market presence from the ground up.
5. Southern Africa
Countries: South Africa, Botswana, Namibia, Zimbabwe, Zambia, Malawi, Mozambique, Angola, Lesotho, Eswatini
Southern Africa is home to the continent’s most sophisticated pharmaceutical market — especially South Africa, which has strong infrastructure, ethical marketing rules, and advanced logistics.
Key Opportunities:
-
Promote clinical data to build physician trust
-
Get listed in major hospital and retail pharmacy systems
-
Participate in formal tenders and private sector procurement
What We Offer:
From SAHPRA registration to salesforce deployment, we help your team speak the right language, follow the right process, and grow in the right direction.
💡 AUM Consultancy: Your Sales Strategy Ally Across Africa
Our approach isn’t “one-size-fits-all.” We offer targeted pharma export consultancy, designed for each African zone’s unique environment. From pricing strategies to KOL engagement, from training medical reps to localizing your message, we walk with you through every step.
We bring:
-
Local market intelligence
-
In-country regulatory know-how
-
Deep experience in government & private sector sales
-
Ready networks of distributors and medical professionals
-
SEO-aligned, culturally adapted brand messaging
📞 Let’s Bring Your Pharma Brand to Life in Africa
Whether you're looking to launch a new product, expand your presence, or boost current performance — we’re here to help.
📩 Contact us for sales & regulatory support in Africa
🔗 Explore our pharma logistics & training services
🌐 Let’s build your roadmap across LATAM, GCC, SEA, CIS & Russia next →
We turn ambition into execution — one country at a time.
Pharma Market Overview: GCC Region
The Gulf Cooperation Council (GCC) — comprising Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, and Oman — represents one of the fastest-growing pharmaceutical markets globally. Fueled by rising healthcare investments, population growth, and a shift toward local manufacturing, the GCC offers strong opportunities for pharma companies seeking sustainable market access.
Regulatory Authorities in the GCC
Each country has its own regulatory body, although there is increasing collaboration toward unified guidelines and fast-track pathways:
-
Saudi Arabia: Saudi Food and Drug Authority (SFDA) – one of the region’s most stringent and structured systems; requires detailed CTD dossier, pharmacovigilance system, and Arabic labeling.
-
UAE: Ministry of Health and Prevention (MOHAP) – emphasizes fast-track approvals, pricing transparency, and local representation.
-
Kuwait, Bahrain, Qatar, Oman: All follow similar pathways, often accepting GCC-wide certificates and requiring in-country agents or distributors.
GCC Central Registration System (GCC-DR): This pathway allows companies to register their products in one Gulf state and then extend it to others, streamlining the process for generics and branded medicines.
📦 Distributor Landscape in the GCC
The pharmaceutical supply chain in the GCC is heavily relationship-driven, with a small number of well-established national distributors dominating each market:
-
Saudi Arabia: Al-Dawaa, Tabuk, SPIMACO, Sudair Pharma
-
UAE: Neopharma, Pharmatrade, Globalpharma
-
Kuwait & Qatar: Advanced Pharma, Kuwait Drug Store, Al Ittihad
-
Bahrain & Oman: Bahrain Pharmacy, Oman Drug Store, National Pharma
Many regulators require a local distributor or agent to register and market products, making trusted partnerships essential. AUM Consultancy assists clients in identifying compliant, performance-driven distributors and negotiating fair commercial terms.
📊 Emerging Pharma Trends in the GCC
-
Localization of Manufacturing
Governments, especially in Saudi Arabia and UAE, are pushing for local production through incentives, joint ventures, and national strategies. This creates a unique window for third-party manufacturing partnerships or setting up fill-finish operations. -
Biologics & Specialty Drugs
There is increasing demand for oncology, immunology, rare disease, and biosimilars, especially in the UAE and Saudi Arabia. Fast-track pathways for biologics are being explored by SFDA and MOHAP. -
Digital Health & e-Pharmacies
Post-COVID, GCC countries have accelerated the adoption of digital prescription platforms, telehealth, and AI-based diagnosis, creating new distribution models and marketing channels. -
Pharmacovigilance and Post-Marketing Surveillance
GCC regulators are placing greater emphasis on risk management plans (RMPs), adverse event reporting, and real-world evidence. Pharmacovigilance departments are now essential to compliance.
🌐 How AUM Consultancy Supports GCC Market Entry
At AUM Consultancy, we help pharma companies:
-
Navigate regulatory requirements across all GCC countries
-
Prepare dossiers, translations, GMP certifications, and local rep agreements
-
Identify and connect with compliant, trustworthy distributors
-
Localize sales, branding, and marketing campaigns
-
Establish third-party manufacturing and tech-transfer strategies
-
Set up pharmacovigilance and local safety reporting systems.
-
📞 Ready to Expand into the GCC?
Let us guide your market access journey across the Gulf with deep regional insight, regulatory precision, and strong local networks.
📩 Contact us for GCC pharma strategy support
🔗 Explore Third-Party Manufacturing in the Middle East
🧭 Book a free consultation for regional entry planning
Pharma Opportunities in LATAM
The Latin American pharmaceutical market — covering key economies like Brazil, Mexico, Argentina, Colombia, Chile, and Peru — is projected to exceed $100 billion in value by 2028. Rapid urbanization, government-backed healthcare reforms, and increasing demand for chronic disease treatments are fueling consistent year-on-year growth.
However, the region is also complex and highly regulated, requiring country-specific strategies, local partnerships, and a strong understanding of compliance frameworks.
✅ Regulatory Authorities in LATAM
Each LATAM country has its own health authority and unique set of regulations. While many accept ICH, WHO, or USFDA guidelines, most require localized documentation, legal representation, and long timelines for product registration.
🇧🇷 Brazil – ANVISA (Agência Nacional de Vigilância Sanitária)
-
One of the most complex and rigorous regulatory systems in the region
-
CTD/eCTD submissions, local GMP audits, and labeling in Portuguese
-
Average time to registration: 12–18 months
🇲🇽 Mexico – COFEPRIS
-
Moderate regulatory process with recent reforms aimed at speeding up approvals
-
Local MAH (Marketing Authorization Holder) is mandatory
-
GMP from recognized agencies (EMA, USFDA) can help fast-track
🇦🇷 Argentina – ANMAT
-
Evolving regulatory landscape with growing biologics and biosimilar interest
-
GMP inspections may be required depending on product type
-
Importation can be affected by currency controls and political cycles
🇨🇴 Colombia – INVIMA
-
Fastest-growing regulatory body in the region
-
High demand for oncology, biosimilars, and specialty products
-
Accepts reference country approvals and regional harmonization
🇨🇱 Chile, 🇵🇪 Peru, 🇺🇾 Uruguay, 🇵🇾 Paraguay
-
Smaller but agile regulatory bodies
-
Good entry points for OTCs, generics, and wellness products
-
Regional registration can be leveraged to build scale
Note: AUM Consultancy ensures you meet both local documentation and regulatory timelines, while identifying fast-track or reliance pathways when available.
🤝 Distributor Networks in LATAM
Distributors play a pivotal role in LATAM, acting not only as importers but often as your local MAH, sales force, and even pharmacovigilance partner.
-
Brazil: EMS, Eurofarma, Hypera Pharma, Biolab
-
Mexico: Marzam, Nadro, Farmacias del Ahorro, Casa Saba
-
Argentina: Roemmers, Bagó, Elea
-
Colombia & Chile: Disprofarma, Tecnoquímicas, Socofar
Working with reliable, compliance-ready distributors is critical. We support our clients by vetting local players based on regulatory track record, distribution reach, pricing models, and credit terms.
📈 LATAM Pharma Market Trends
-
Biologics & Biosimilars Boom
LATAM regulators are embracing biosimilar pathways, especially in Brazil, Mexico, and Colombia. There’s a growing need for oncology, autoimmune, and rare disease treatments. -
Public Procurement & Tender Systems
Government-funded health systems (e.g., SUS in Brazil, IMSS in Mexico) are major buyers of generics, vaccines, and essential medicines. Knowing how to navigate tenders and registration timelines is essential. -
Localized Production Incentives
Brazil, Argentina, and Mexico are incentivizing local manufacturing. Companies can benefit from tech transfer, licensing deals, or toll manufacturing via regional CDMOs. -
Pricing Pressures & Currency Volatility
LATAM markets are price-sensitive, and companies must account for exchange rate fluctuations and local tax burdens when planning launch strategies. -
E-pharmacies & Retail Consolidation
Retail pharmacy chains and digital pharma platforms are growing rapidly, particularly in Mexico, Brazil, and Chile, offering direct-to-consumer access and promotional avenues.
🌐 How AUM Consultancy Helps You Win in LATAM
We don’t just translate your documents — we translate your vision into reality. Our Latin America support includes:
-
Regulatory submission & dossier preparation
-
Legal representation and MAH setup
-
Distributor identification and negotiation
-
Sales & marketing strategy localization
-
Tender participation support & pharmacovigilance compliance
-
Third-party manufacturing partnerships in-region
📞 Ready to Enter the LATAM Market?
If you’re looking to establish or scale your pharmaceutical presence in Latin America, AUM Consultancy will walk with you every step of the way — from compliance to commercialization.
📩 Contact us for LATAM regulatory and distributor support
🔗 Explore manufacturing & licensing opportunities in Brazil and Mexico
Why South East Asia (SEA) Is the Next Big Opportunity in Pharma
Southeast Asia is quickly becoming one of the world’s most promising pharmaceutical markets. From the bustling cities of Indonesia and Vietnam to the highly regulated systems of Singapore and Malaysia, this region offers something unique: a blend of population-driven demand, rising healthcare investment, and a growing hunger for better treatments.
But it’s not a one-size-fits-all market. Every country has its own rules, culture, and pace. That’s why having the right guidance makes all the difference.
✅ Understanding the Regulators: One Region, Many Systems
Unlike the EU or GCC, Southeast Asia doesn’t follow a unified regulatory system — at least not yet. But many countries are slowly aligning with international standards, and the ASEAN Common Technical Dossier (ACTD) is helping to make things smoother.
Here’s what you should know about the key players:
-
Indonesia (BPOM): Requires a local registration holder and favors companies with local manufacturing ties. Timelines can be long, so planning ahead is critical.
-
Vietnam (DAV): A high-demand market, especially for biosimilars and generics, but be prepared for delays.
-
Thailand (Thai FDA): A great place for wellness and OTC products. Private hospitals are booming, but government systems are slow and tender-driven.
-
Philippines (FDA Philippines): Regulation is improving, especially for digital submissions. The market is price-sensitive, and relationships matter.
-
Malaysia (NPRA): Efficient and modern. Halal certification is important here, especially for OTC and supplements.
-
Singapore (HSA): Arguably the most advanced in the region. Approvals are quick, making Singapore an ideal launch hub or clinical trial base.
At AUM Consultancy, we help you translate your global dossier into local success, ensuring your applications, packaging, and labeling meet each country’s exact standards.
🤝 The People Who Move Your Products: Local Distributors
Your success in Southeast Asia often comes down to who you partner with. Distributors here are not just logistics providers — they’re your sales team, market reps, and sometimes even your legal registration holders.
Top names include:
-
Kalbe Farma (Indonesia)
-
UNILAB (Philippines)
-
Zuellig Pharma (Regional)
-
Imexpharm (Vietnam)
-
DKSH and Mega Lifesciences (Thailand)
-
Pharmaniaga (Malaysia)
Finding the right partner isn’t just about reach — it’s about compliance, experience, and trust. That’s why we at AUM Consultancy thoroughly vet and match you with distributors aligned to your market goals.
📈 SEA Market Trends You Can’t Afford to Miss
Digital Pharma is Growing Fast
🌍 Pharma Consultancy | AUM Consultancy BJ | Russia & CIS
Welcome to AUM Consultancy BJ – your growth partner in the complex world of International Pharma. If you're looking to step confidently into the Russia & CIS Region, you're in the right place.
We help pharma companies do more than just export — we help you enter, understand, and expand in new markets. Whether it's cracking regulatory codes, researching untapped markets, navigating public sector tenders, or getting your product into the right hands—we’ve got your back.
👋 Who We Are?
Think of us as your boots-on-the-ground team for Russia & the CIS. At AUM Consultancy BJ, we don’t just offer advice — we walk with you every step of the way, from compliance to commercial success.
We bring together expertise in:
-
Regulatory affairs
-
Market research & insights
-
Sales & marketing strategy
-
Procurement & tender participation (B2B, B2C, B2G)
Whether you're a manufacturer, exporter, distributor, or healthcare provider, we simplify your global pharma journey.
💡 What We Do (and Do Well)
📜 Regulatory Affairs: No More Guesswork
The regulatory landscape in Russia & CIS can be a maze — but not when you have us. We:
-
Prepare and submit compliant dossiers
-
Handle WHO-GMP and country-specific registrations
-
Translate and adapt labels as per local rules
-
Help you stay compliant, even post-approval
We turn red tape into green signals.
📊 Market Research & Real-World Insights
Success in a new region starts with knowing the terrain. We provide:
-
On-ground market research & demand analysis
-
Product positioning and competitor benchmarking
-
Country-specific trends and pricing intel
Get the market insights that matter — not just data, but direction.
🧠 Sales & Marketing Support
Launching a product is one thing — making it fly is another. Our sales & marketing playbook includes:
-
Distributor matchmaking and deal facilitation
-
Multilingual marketing content
-
B2B campaign planning for pharma trade networks
-
B2C push through pharmacies and clinics
We help you build trust, brand, and buzz — locally and digitally.
🏛️ Tender Business (B2G) – Government Contracts Made Simple
Governments across Russia & CIS run high-volume public tenders. With the right support, your company can win them.
We guide you through the B2G landscape by:
-
Registering with tender authorities
-
Preparing documentation and proposals
-
Managing compliance for state contracts
-
Ensuring supply chain readiness
Your success in government tenders starts with strategy — and we bring that to the table.
🏬 Procurement Services – End-to-End Solutions
As a procurement agent, we source and supply:
-
Allopathic medicines (generic & branded)
-
Specialty drugs & life-saving formulations
-
Medical consumables & diagnostic kits
We cater to B2B, B2C, and B2G needs — ensuring quality, continuity, and competitive pricing.
🌐 Where We Work
From our base in India to our active network in Russia & the CIS Region, we operate where your opportunities lie. Our consultants understand local languages, systems, and market nuances — so your business doesn't just land, it thrives.
💼 Why AUM Consultancy BJ?
Because we don’t believe in one-size-fits-all.
Here’s what makes us different:
-
✅ Deep knowledge of Russia & CIS pharma markets
-
✅ Real-time coordination with buyers, importers & health ministries
-
✅ Expertise across B2B, B2C, and B2G
-
✅ Strategic, ethical, and culturally aware execution
-
✅ Transparent communication and timely delivery
🤝 Let's Partner for Global Success
Whether you're trying to register a drug, win a tender, find distributors, or source the right products, AUM Consultancy BJ is ready to help.
We’re more than consultants — we’re your global growth allies.
🔗 Website: www.aumconsultancybj.com
📧 Email: info@aumconsultancybj.com
📍 Offices: India & West Africa
Keep In Touch
A Global Business Consultant
French West Africa is the Land of Business Opportunites
